Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_assertion type Assertion NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_head.
- NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_assertion description "[Nondemented APOE e4 carriers over age 60 have a higher burden of total parenchymal and vascular amyloid neuropathology than NC, but no difference in neuritic plaque and NFT pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_provenance.
- NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_assertion evidence source_evidence_literature NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_provenance.
- NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_assertion SIO_000772 20153809 NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_provenance.
- NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_assertion wasDerivedFrom befree-20150227 NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_provenance.
- NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_assertion wasGeneratedBy ECO_0000203 NP245696.RANKsrzYjdVLxVz0sigrIUeJIpgCh4xgAzqDw_K7CaCr0130_provenance.